Inhibikase

+$0.01 (+0.35%) Today
+$0.01 (+0.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Inhibikase and other stocks, options, and ETFs commission-free!

About IKT

Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases.

CEO
Milton H. Werner
Employees
8
Headquarters
Atlanta, Georgia
Founded
2008

IKT Key Statistics

Market Cap
58.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.50M
High Today
$2.92
Low Today
$2.82
Open Price
$2.88
Volume
1.37M
52 Week High
$11.80
52 Week Low
$2.82

IKT Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure